In 18 of 20 patients with psychosis secondary to systemic lupus erythematosus (SLE), autoantibodies to ribosomal P proteins were detected by immunoblotting and measured with a new radioimmunoassay using a synthetic peptide as antigen. The frequency of anti-P was not increased in patients with other central nervous system manifestations of SLE (3 of 20, by radioimmunoassay), in patients with transient behavioral abnormalities due to SLE (none of 8), in patients with psychosis who did not have SLE (none of 13), or in normal controls (none of 20). In four of five paired serum samples, anti-P-peptide antibody levels increased 5-fold to 30-fold during the active phase of lupus psychosis. Longitudinal studies of anti-P activity in two patients with psychosis revealed that anti-P levels increased before and during the active phases of psychosis but not during sepsis or other exacerbations of SLE, and that the elevations were selective for anti-P antibodies, as opposed to anti-DNA antibodies. Longitudinal studies of anti-P activity in two patients with anti-P but without psychosis showed less than threefold changes in anti-P levels despite exacerbations of disease. We conclude that anti-P is associated with lupus psychosis and that synthetic peptide antigens may be useful for the detection and measurement of autoantibodies to intracellular proteins.
This article has been cited by other articles:
Haddouk, S., Marzouk, S., Jallouli, M., Fourati, H., Frigui, M., Hmida, Y. B. H., Koubaa, F., Sellami, W., Baklouti, S., Hachicha, J., Bahloul, Z., Masmoudi, H.
(2009). Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus. Rheumatology (Oxford)
48: 953-957
[Abstract][Full Text]
Paran, D, Litinsky, I, Shapira-Lichter, I, Navon, S, Hendler, T, Caspi, D, Vakil, E
(2009). Impaired memory and learning abilities in patients with systemic lupus erythematosus as measured by the Rey Auditory Verbal Learning Test. Ann Rheum Dis
68: 812-816
[Abstract][Full Text]
Massardo, L, Metz, C, Pardo, E, Mezzano, V, Babul, M, Jarpa, E, Guzman, A., Andre, S, Kaltner, H, Gabius, H., Jacobelli, S, Gonzalez, A, Soza, A
(2009). Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation. Lupus
18: 539-546
[Abstract]
JURENCAK, R., FRITZLER, M., TYRRELL, P., HIRAKI, L., BENSELER, S., SILVERMAN, E.
(2009). Autoantibodies in Pediatric Systemic Lupus Erythematosus: Ethnic Grouping, Cluster Analysis, and Clinical Correlations. The Journal of Rheumatology
36: 416-421
[Abstract][Full Text]
Santer, D. M., Yoshio, T., Minota, S., Moller, T., Elkon, K. B.
(2009). Potent Induction of IFN-{alpha} and Chemokines by Autoantibodies in the Cerebrospinal Fluid of Patients with Neuropsychiatric Lupus. J. Immunol.
182: 1192-1201
[Abstract][Full Text]
Hanly, J.
(2008). The neuropsychiatric SLE SLICC inception cohort study. Lupus
17: 1059-1063
Kimura, A., Sakurai, T., Tanaka, Y., Hozumi, I., Takahashi, K., Takemura, M., Saito, K., Seishima, M., Inuzuka, T.
(2008). Proteomic analysis of autoantibodies in neuropsychiatric systemic lupus erythematosus patient with white matter hyperintensities on brain MRI. Lupus
17: 16-20
[Abstract]
Matus, S., Burgos, P. V., Bravo-Zehnder, M., Kraft, R., Porras, O. H., Farias, P., Barros, L. F., Torrealba, F., Massardo, L., Jacobelli, S., Gonzalez, A.
(2007). Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. JEM
204: 3221-3234
[Abstract][Full Text]
Bartolucci, P., Brechignac, S., Cohen, P., Le Guern, V., Guillevin, L.
(2007). Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients. Lupus
16: 817-822
[Abstract]
Ishii, M, Muramoto, Y, Kosaka, H, Ohshima, S, Mima, T, Katada, Y, Hirohata, S, Saeki, Y
(2007). A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis, profundus and psychosis). Lupus
16: 67-69
Kowal, C., DeGiorgio, L. A., Lee, J. Y., Edgar, M. A., Huerta, P. T., Volpe, B. T., Diamond, B.
(2006). From the Cover: Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. USA
103: 19854-19859
[Abstract][Full Text]
Mahler, M., Kessenbrock, K., Szmyrka, M., Takasaki, Y., Garcia-De La Torre, I., Shoenfeld, Y., Hiepe, F., Shun-le, C., von Muhlen, C. A., Locht, H., Hopfl, P., Wiik, A., Reeves, W., Fritzler, M. J.
(2006). International Multicenter Evaluation of Autoantibodies to Ribosomal P Proteins. CVI
13: 77-83
[Abstract][Full Text]
Ebert, T, Chapman, J, Shoenfeld, Y
(2005). Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?. Lupus
14: 571-575
[Abstract]
Chen, M.-Y., Lee, K.-L., Hsu, P.-N., Wu, C.-S., Wu, C.-H.
(2004). Is there an ethnic difference in the prevalence of lupus cystitis? A report of six cases. Lupus
13: 263-269
[Abstract]
Gerli, R., Caponi, L., Tincani, A., Scorza, R., Sabbadini, M. G., Danieli, M. G., De Angelis, V., Cesarotti, M., Piccirilli, M., Quartesan, R., Moretti, P., Cantoni, C., Franceschini, F., Cavazzana, I., Origgi, L., Vanoli, M., Bozzolo, E., Ferrario, L., Padovani, A., Gambini, O., Vanzulli, L., Croce, D., Bombardieri, S.
(2002). Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford)
41: 1357-1366
[Abstract][Full Text]
Massardo, L, Burgos, P, Martinez, M E, Perez, R, Calvo, M, Barros, J, Gonzalez, A, Jacobelli, S
(2002). Antiribosomal P protein antibodies in Chilean SLE patients: no association with renal disease. Lupus
11: 379-383
[Abstract]
Takeda, I, Rayno, K, Movafagh, F B, Wolfson-Reichlin, M, Reichlin, M
(2001). Dual binding capabilities of anti-double-stranded DNA antibodies and anti-ribosomal phosphoprotein (P) antibodies. Lupus
10: 857-865
[Abstract]
Hirohata, S, Nakanishi, K
(2001). Antiribosomal P protein antibody in human systemic lupus erythematosus reacts specifically with activated T cells. Lupus
10: 612-621
[Abstract]
Sun, K.-H., Tang, S.-J., Lin, M.-L., Wang, Y.-S., Sun, G.-H., Liu, W.-T.
(2001). Monoclonal antibodies against human ribosomal P proteins penetrate into living cells and cause apoptosis of Jurkat T cells in culture. Rheumatology (Oxford)
40: 750-756
[Abstract][Full Text]
Svenungsson, E, Andersson, M, Brundin, L, van Vollenhoven, R, Khademi, M, Tarkowski, A, Greitz, D, Dahlstrom, M, Lundberg, I, Klareskog, L, Olsson, T
(2001). Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis
60: 372-379
[Abstract][Full Text]
Ghirardello, A, Doria, A, Zampieri, S, Gerli, R, Rapizzi, E, Gambari, P F
(2000). Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ann Rheum Dis
59: 975-981
[Abstract][Full Text]
Weiner, S M, Otte, A, Schumacher, M, Klein, R, Gutfleisch, J, Brink, I, Otto, P, Nitzsche, E U, Moser, E, Peter, H H
(2000). Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis
59: 377-385
[Abstract][Full Text]
Tzioufas, A G, Tzortzakis, N G, Panou-Pomonis, E, Boki, K A, Sakarellos-Daitsiotis, M, Sakarellos, C, Moutsopoulos, H M
(2000). The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease. Ann Rheum Dis
59: 99-104
[Abstract][Full Text]
Whitelaw, D A, Spangenberg, J J, Rickman, R, Hugo, F H, Roberts, M
(1999). The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE. Lupus
8: 444-448
[Abstract]
Agius, M. A., Chan, J. W., Chung, S., Lee, E.-K.
(1997). Role of Antiribosomal P Protein Antibodies in the Diagnosis of Lupus Isolated to the Central Nervous System. Arch Neurol
54: 862-864
[Abstract]
Hamasaki, K., Mimura, T., Kanda, H., Morino, N., Yazaki, Y., Nojimal, Y.
(1997). Development of systemic lupus erythematosus in a rheumatoid arthritis patient with anti-ribosomal P protein antibody. Lupus
6: 734-736
[Abstract]
Iverson, G.
(1996). Are Antibodies to Ribosomal P Proteins a Clinically Useful Predictor of Neuropsychiatric Manifestations in Patients with Systemic Lupus Erythematosus?. Lupus
5: 634-635
Watanabe, T., Sato, T., Uchiumi, T., Arakawa, M.
(1996). Neuropsychiatric manifestations in patients with systemic lupus erythematosus: Diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody. Lupus
5: 178-183
[Abstract]
Martin, A., Reichlin, M.
(1996). Fluctuations of antibody to ribosomal P proteins correlate with appearance and remission of nephritis in SLE. Lupus
5: 22-29
[Abstract]
Hanly, J. G., Fisk, J. D., Eastwood, B.
(1994). Brain Reactive Autoantibodies and Cognitive Impairment in Systemic Lupus Erythematosus. Lupus
3: 193-199
[Abstract]
Matsukawa, Y., Sawada, S., Hayama, T., Usui, H., Horie, T.
(1994). Suicide in Patients with Systemic Lupus Erythematosus: A Clinical Analysis of Seven Suicidal Patients. Lupus
3: 31-35
[Abstract]
Hanly, J. G., Hong, C., White, T. D.
(1993). Brain Synaptosomal Antibodies in Systemic Lupus Erythematosus. Lupus
2: 35-45
[Abstract]
Martinez, X., Tintore, M., Montalban, J., Ordi, J., Vilardell, M., Codina, A.
(1992). Antibodies against Gangliosides in Patients with SLE and Neurological Manifestations. Lupus
1: 299-302
[Abstract]
Takehara, K., Nojima, Y., Kikuchi, K., Igarashi, A., Soma, Y., Tsuchida, T., Ishibashi, Y.
(1990). Systemic Lupus Erythematosus Associated With Antiribosomal P Protein Antibody. Arch Dermatol
126: 1184-1186
[Abstract]
Previous
